ATTENTION ZYME SHAREHOLDERS Investors who Lost Money on Zymeworks Inc. are Urged to Contact Levi Korsinsky about an Ongoing Investigation
ZYME Stock | USD 12.74 0.66 4.93% |
About 64% of Zymeworks Common's investor base is looking to short. The analysis of the overall investor sentiment regarding Zymeworks Common Stock suggests that many traders are alarmed. The current market sentiment, together with Zymeworks Common's historical and current headlines, can help investors time the market. In addition, many technical investors use Zymeworks Common Stock stock news signals to limit their universe of possible portfolio assets.
Zymeworks |
NEW YORK, NY ACCESSWIRE April 19, 2024 Levi Korsinsky notifies investors that it has commenced an investigation of Zymeworks Inc. concerning possible violations of
Read at accesswire.com
![]() |
Zymeworks Common Stock Current Investor Sentiment
Comfort Level 36
Alarmed
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Zymeworks Common's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Zymeworks Common Stock.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Zymeworks Common Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Zymeworks Common can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Zymeworks Common Fundamental Analysis
We analyze Zymeworks Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zymeworks Common using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zymeworks Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Zymeworks Common is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Zymeworks Common Stock Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Zymeworks Common stock to make a market-neutral strategy. Peer analysis of Zymeworks Common could also be used in its relative valuation, which is a method of valuing Zymeworks Common by comparing valuation metrics with similar companies.
Peers
Zymeworks Common Related Equities
PTGX | Protagonist Therapeutics | 2.42 | ||||
SNDX | Syndax Pharmaceuticals | 1.02 | ||||
APLS | Apellis Pharmaceuticals | 4.33 | ||||
BLUE | Bluebird Bio | 4.90 | ||||
STOK | Stoke Therapeutics | 5.73 | ||||
RVMD | Revolution Medicines | 5.89 | ||||
RLAY | Relay Therapeutics | 6.16 | ||||
ARWR | Arrowhead Pharmaceuticals | 6.35 | ||||
YMAB | Y MAbs | 6.65 | ||||
CYTK | Cytokinetics | 6.76 | ||||
BPMC | Blueprint Medicines | 7.06 | ||||
ZNTL | Zentalis Pharmaceuticals | 7.25 | ||||
AKRO | Akero Therapeutics | 7.29 | ||||
TVTX | Travere Therapeutics | 7.48 | ||||
MRSN | Mersana Therapeutics | 7.69 | ||||
CABA | Cabaletta Bio | 7.73 | ||||
EDIT | Editas Medicine | 7.81 | ||||
TERN | Terns Pharmaceuticals | 8.13 | ||||
PRQR | ProQR Therapeutics | 8.58 | ||||
DAWN | Day One | 8.94 | ||||
INZY | Inozyme Pharma | 9.17 | ||||
ANNX | Annexon | 9.47 | ||||
ALEC | Alector | 14.02 |
Complementary Tools for Zymeworks Stock analysis
When running Zymeworks Common's price analysis, check to measure Zymeworks Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zymeworks Common is operating at the current time. Most of Zymeworks Common's value examination focuses on studying past and present price action to predict the probability of Zymeworks Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zymeworks Common's price. Additionally, you may evaluate how the addition of Zymeworks Common to your portfolios can decrease your overall portfolio volatility.
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Transaction History View history of all your transactions and understand their impact on performance | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |